Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese HSK 1 – For Medical Students & Physicians A complete 20-lesson, 300-page Chinese HSK 1 course with a companion app in 21 languages — free forever. Arabic, Bengali, Dutch, English, Farsi, French, German, Hindi, Indonesian, Italian, Japanese, Korean, Portuguese, Russian, Spanish, Tagalog, Thai, Turkish, Ukrainian, Urdu, Vietnamese. By Bernd Sebastian Kamps and Andrea Melis

Pulmonary Hypertension

Free Subscription 06.04.2026 1 Am J Physiol Lung Cell Mol Physiol 1 Anatol J Cardiol 1 Animal Model Exp Med 2 Ann Am Thorac Soc 1 Biomed Res Int 1 Biomedicines 1 BMC Pregnancy Childbirth 1 BMJ Open Respir Res 1 Cardiol Young 3 Circulation 1 Clin Res Cardiol 1 Commun Biol 1 Compr Physiol 1 Cureus 4 Echocardiography 1 ESC Heart Fail 1 Eur Respir J 1 Expert Rev Respir Med 1 Heart Lung 1 Int Heart J 3 Int J Mol Sci 1 Int J Obstet Anesth 1 J Am Soc Echocardiogr 1 J Cardiothorac Vasc Anesth 1 J Cardiovasc Dev Dis 1 J Electrocardiol 1 J Endovasc Ther 1 J Ethnopharmacol 1 J Mol Med (Berl) 2 J Nanobiotechnology 1 J Proteome Res 1 J Soc Cardiovasc Angiogr Interv 1 J Spec Oper Med 1 J Thorac Cardiovasc Surg 1 J Vet Intern Med 1 JACC Asia 1 JACC Basic Transl Sci 1 JACC CardioOncol 1 JACC Case Rep 1 Neonatology 1 Orphanet J Rare Dis 1 Radiol Case Rep 1 Respir Med 1 Respir Res 1 Rev Cardiovasc Med 1 Sarcoidosis Vasc Diffuse Lung Dis 1 Sci Rep 1 Turk Kardiyol Dern Ars 1 Zhongguo Dang Dai Er Ke Za Zhi

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Physiol Lung Cell Mol Physiol

1. BAI AS, Sorensen GL, Sundaram AB, Chang W, et al
   The emerging role of integrin signaling in pulmonary vascular disease.
   Am J Physiol Lung Cell Mol Physiol. 2026;330:L476-L486.
   PubMed         Abstract available
   
   

   
   Anatol J Cardiol

2. EROL C
   Selexipag for Pulmonary Hypertension, TAVI and more.
   Anatol J Cardiol. 2026;30:212.
   PubMed        
   
   

   
   Animal Model Exp Med

3. LIU X, Zheng X, Zhang Y, Fang Y, et al
   Complementary multi-omics profiling of chronic thromboembolic pulmonary hypertension reveals immune cell alterations, epigenetic changes, and genetically supported candidate genes.
   Animal Model Exp Med. 2026 Mar 31. doi: 10.1002/ame2.70166.
   PubMed         Abstract available
   
   

   
   Ann Am Thorac Soc

4. COUCH TJ, Beck GJ, Berman-Rosenzweig E, Carr JJ, et al
   Pulmonary artery size on computed tomography associates with mean pulmonary artery pressure and mortality.
   Ann Am Thorac Soc. 2026;23:494-505.
   PubMed         Abstract available
   
   
5. KRAMER T, Weis H, Kural M, Kramer M, et al
   Correlation of ventilation-perfusion mismatch with hemodynamics in chronic thromboembolic pulmonary hypertension: a quantitative V/Q SPECT analysis.
   Ann Am Thorac Soc. 2026;23:646-650.
   PubMed        
   
   

   
   Biomed Res Int

6. WU P, Zhong D, He X, Li Y, et al
   The Potential Role of Calcium Channels in Pulmonary Hypertension.
   Biomed Res Int. 2026;2026:e4121036.
   PubMed         Abstract available
   
   

   
   Biomedicines

7. ARTEMIEVA M, Kozaeva L, Kuropatkina T, Gufranov K, et al
   Molecular Hydrogen Modulates the Baroreflex Activity and Reduces the Vascular Adrenoreceptor Sensitivity to Phenylephrine and Lung Inflammation in Rats with Pulmonary Hypertension.
   Biomedicines. 2026;14:494.
   PubMed         Abstract available
   
   

   
   BMC Pregnancy Childbirth

8. SUN Y
   The preoperative risks of pulmonary hypertension crisis for the cesarean puerpera with pulmonary artery hypertension.
   BMC Pregnancy Childbirth. 2026 Apr 1. doi: 10.1186/s12884-026-08736.
   PubMed        
   
   

   
   BMJ Open Respir Res

9. ZHENG S, Li Y, Liu Z, Chen Y, et al
   Pulmonary hypertension in Takayasu arteritis with pulmonary artery involvement: risk factors and impact on mortality.
   BMJ Open Respir Res. 2026;13:e003854.
   PubMed         Abstract available
   
   

   
   Cardiol Young

10. TORUN EG, Dogan O, Bagrul D, Ece I, et al
    Individualised interventional strategies and clinical outcomes in paediatric patients with pulmonary arterial hypertension.
    Cardiol Young. 2026;36:294-305.
    PubMed         Abstract available
    
    

    
    Circulation

11. FORBES LM, Cornwell WK
    Group 1 Pulmonary Hypertension With Elevated Pulmonary Artery Wedge Pressure: Characterizing A Complex Phenotype.
    Circulation. 2026;153:963-966.
    PubMed        
    
    
12. JAMBON-BARBARA C, Suissa S, Dell'Aniello S, Hlavaty A, et al
    Second- and Third-Generation BCR-ABL Tyrosine Kinase Inhibitors and the Risk of Pulmonary Arterial Hypertension: A Prevalent New-User Design.
    Circulation. 2026 Feb 12. doi: 10.1161/CIRCULATIONAHA.125.077764.
    PubMed         Abstract available
    
    
13. GOMBERG-MAITLAND M, Tedford RJ, Langleben D, Rosenkranz S, et al
    Sotatercept for Combined Post- and Pre-capillary Pulmonary Hypertension Associated With Heart Failure: Results from the Phase 2, Randomized, Placebo-Controlled CADENCE Study.
    Circulation. 2026 Mar 29. doi: 10.1161/CIRCULATIONAHA.126.079918.
    PubMed         Abstract available
    
    

    
    Clin Res Cardiol

14. FUMAGALLI RM, Zbinden S, Cardi S, Furbringer-Schwarz A, et al
    Post-pulmonary embolism cardiac impairment and chronic thromboembolic pulmonary hypertension after ultrasound-assisted catheter-directed thrombolysis for acute pulmonary embolism.
    Clin Res Cardiol. 2026 Mar 30. doi: 10.1007/s00392-026-02894.
    PubMed         Abstract available
    
    

    
    Commun Biol

15. YI L, He W, He C, Shi X, et al
    ALDOB K87 lactylation drives mitochondrial fission and metabolic reprogramming in pulmonary hypertension.
    Commun Biol. 2026 Mar 27. doi: 10.1038/s42003-026-09934.
    PubMed         Abstract available
    
    

    
    Compr Physiol

16. SINGH N, DuBrock HM, Prisco SZ, Dai Z, et al
    The Importance of Liver-Lung Communication in Pulmonary Vascular Diseases.
    Compr Physiol. 2026;16:e70140.
    PubMed         Abstract available
    
    

    
    Cureus

17. JURTH T, Marasco S
    Chronic Thromboembolic Pulmonary Hypertension: A Narrative Review.
    Cureus. 2026;18:e104418.
    PubMed         Abstract available
    
    

    
    Echocardiography

18. ZHANG Z, Shi Y, Liu Y, Cao Y, et al
    Echocardiographic Evaluation of Global Cardiac Function in Systemic Sclerosis-Associated Pulmonary Arterial Hypertension: An Integrated Review of Parameters and Techniques.
    Echocardiography. 2026;43:e70442.
    PubMed         Abstract available
    
    
19. TIAN Y, Huang CL, Zhou H, Wang WD, et al
    A Novel Quantification Method for Ventricular Septal Curvature in Pulmonary Hypertension Associated With Left Heart Disease.
    Echocardiography. 2026;43:e70436.
    PubMed         Abstract available
    
    
20. GAUDIO D, Piscione M, Pala B, De Mitri S, et al
    TAPSE/sPAP Ratio in Systemic Sclerosis: Evidence From Pulmonary Hypertension and Implications for Early Risk Stratification-A Systematic Review.
    Echocardiography. 2026;43:e70440.
    PubMed         Abstract available
    
    
21. SANTOSO YACE, Marsam RK, Anggrahini DW, Hartopo AB, et al
    Accuracy of Echocardiographic Parameters in Diagnosing Pulmonary Hypertension in Adult Patients With Uncorrected Secundum Atrial Septal Defect.
    Echocardiography. 2026;43:e70427.
    PubMed         Abstract available
    
    

    
    ESC Heart Fail

22. GENECAND L, Boucly A, Sitbon O, Montani D, et al
    Does the Method Matter? Direct Fick Versus Thermodilution in the Haemodynamic Assessment of Pulmonary Hypertension.
    ESC Heart Fail. 2026 Mar 27:xvag093. doi: 10.1093.
    PubMed        
    
    

    
    Eur Respir J

23. MOKHLESI B, Hache-Marliere M, Bjork ST, Jain D, et al
    Impact of positive airway pressure therapy on pulmonary arterial pressures in obstructive sleep apnoea or obesity hypoventilation syndrome: a systematic review and meta-analysis.
    Eur Respir J. 2026;67:2501037.
    PubMed         Abstract available
    
    

    
    Expert Rev Respir Med

24. WACKER J, Joye R, Beghetti M
    Treatment options for children with pulmonary arterial hypertension associated with congenital heart disease.
    Expert Rev Respir Med. 2026;20:369-377.
    PubMed         Abstract available
    
    

    
    Heart Lung

25. CHIU K, Parikh T, Pierce Reitnauer J, Khan SA, et al
    The impact of pulmonary hypertension and comorbidities on in-hospital mortality in hypertrophic obstructive cardiomyopathy: A nationwide analysis from 2016 to 2021.
    Heart Lung. 2026;78:102758.
    PubMed         Abstract available
    
    

    
    Int Heart J

26. MORISHITA K, Ishii S, Maki H, Hatano M, et al
    Utility of Acute Vasodilator Challenge with Inhaled Nitric Oxide to Predict Pulmonary Hemodynamic Reversibility in Patients with Pulmonary Hypertension due to Left Heart Disease Referred for Heart Transplantation.
    Int Heart J. 2026;67:150-155.
    PubMed         Abstract available
    
    

    
    Int J Mol Sci

27. CHEN X, Wang X, Xu R, Gao S, et al
    Beyond the Vasculature: The Emerging Role of Systemic Metabolism and Immunometabolism in Pulmonary Arterial Hypertension.
    Int J Mol Sci. 2026;27:2571.
    PubMed         Abstract available
    
    
28. SZARPAK L, Jach ME, Skoczylas M, Radej S, et al
    Clonal Hematopoiesis (CHIP) in Pulmonary Embolism and CTEPH: Evidence, Mechanisms, and Risk Stratification.
    Int J Mol Sci. 2026;27:2750.
    PubMed         Abstract available
    
    
29. FANG X, He Y
    Hypoxic Pulmonary Hypertension: Molecular Mechanisms and Clinical Research Advances.
    Int J Mol Sci. 2026;27:2762.
    PubMed         Abstract available
    
    

    
    Int J Obstet Anesth

30. BAK BM, Kauss ML, Teixeira MT, Sharpe EE, et al
    Neuraxial anesthesia for surgical pregnancy termination in patients with severe pulmonary hypertension: a case series (2019-2025).
    Int J Obstet Anesth. 2026;67:104886.
    PubMed         Abstract available
    
    

    
    J Am Soc Echocardiogr

31. ITURRIAGAGOITIA A, Bove T, De Pauw M, Vandecasteele E, et al
    Tricuspid Regurgitation Peak-to-Mean Velocity Ratio: Linking Doppler Morphology to Right Heart Hemodynamics in Pulmonary Hypertension.
    J Am Soc Echocardiogr. 2026 Mar 30:S0894-7317(26)00132.
    PubMed         Abstract available
    
    

    
    J Cardiothorac Vasc Anesth

32. COSTANZA L, Stead TS, Joyce MF, Maslow M, et al
    Comparing Echocardiography and Right Heart Catheterization for Mortality Prediction in Pulmonary Hypertension.
    J Cardiothorac Vasc Anesth. 2026 Mar 7:S1053-0770(26)00208.
    PubMed         Abstract available
    
    

    
    J Cardiovasc Dev Dis

33. KYLE AR, Jose A, Catherman K, Elwing J, et al
    Real-World Outcomes of Inhaled Treprostinil in Pulmonary Hypertension Related to Interstitial Lung Disease: A Multicenter, Retrospective Analysis.
    J Cardiovasc Dev Dis. 2026;13:129.
    PubMed         Abstract available
    
    

    
    J Electrocardiol

34. PEREZ-RIERA AR, Barbosa-Barros R, da Silva Rocha M, da Silva Rocha CA, et al
    A child with a large ostium secundum atrial septal defect, pulmonary hypertension, and the characteristic Crochetage electro-vectorcardiographic pattern.
    J Electrocardiol. 2026;97:154238.
    PubMed         Abstract available
    
    

    
    J Endovasc Ther

35. HURTADO RENDON IS, Aslam R, Attaran R
    Non-Healing Venous Ulcer Associated With the Triple Threat of Deep Vein Reflux, Tricuspid Valve Regurgitation, and Pulmonary Hypertension.
    J Endovasc Ther. 2026 Apr 3:15266028261436748. doi: 10.1177/15266028261436748.
    PubMed         Abstract available
    
    

    
    J Ethnopharmacol

36. ZHOU Y, Bai Y, Yang S, Wang S, et al
    Integrative elucidation of Panax notoginseng 's action against pulmonary hypertension: Network pharmacology and molecular docking insights.
    J Ethnopharmacol. 2026;365:121546.
    PubMed         Abstract available
    
    

    
    J Mol Med (Berl)

37. LAI YJ, Huang YL, Tsai CY, Chen PR, et al
    TGF-beta-induced autophagy in pulmonary artery endothelial cells associated with chronic thromboembolic pulmonary hypertension.
    J Mol Med (Berl). 2026;104:57.
    PubMed         Abstract available
    
    

    
    J Nanobiotechnology

38. DAI C, Li X, Chu TS, Wan YP, et al
    Neutrophil-mediated delivery of curcumin-loaded manganese-doped zeolitic imidazolate framework-8 nanozymes for pulmonary arterial hypertension.
    J Nanobiotechnology. 2026;24:292.
    PubMed         Abstract available
    
    
39. ZHU Y, Yang X, Cao X, Liu K, et al
    From nanotechnology to immunomodulation: emerging strategies targeting macrophages in high altitude pulmonary hypertension.
    J Nanobiotechnology. 2026 Apr 3. doi: 10.1186/s12951-026-04317.
    PubMed         Abstract available
    
    

    
    J Proteome Res

40. CHEN H, Chen J, Hou C, Rui H, et al
    Identification of Novel Drug Targets for Pulmonary Arterial Hypertension through Integrated Plasma Proteomics.
    J Proteome Res. 2026;25:2123-2134.
    PubMed         Abstract available
    
    

    
    J Soc Cardiovasc Angiogr Interv

41. KATZ JB, Chen K, Cuttica MJ, Mylvaganam R, et al
    Balloon Pulmonary Angioplasty for Chronic Thromboembolic Pulmonary Hypertension: Identifying and Managing Complications for the Operator.
    J Soc Cardiovasc Angiogr Interv. 2025;5:104049.
    PubMed         Abstract available
    
    

    
    J Spec Oper Med

42. RODRIGUEZ JO, Shumway D, Tubbs P, Leek M, et al
    High-Altitude Pulmonary Edema Management in a Special Operator.
    J Spec Oper Med. 2026;26:93-0.
    PubMed         Abstract available
    
    

    
    J Thorac Cardiovasc Surg

43. TAO L, Chuan Z, Zhou H
    Pulmonary venous modeling versus cardiopulmonary reality in group 2 pulmonary hypertension.
    J Thorac Cardiovasc Surg. 2026 Apr 1:S0022-5223(26)00176.
    PubMed        
    
    

    
    J Vet Intern Med

44. STAVRI A, Krasnow M, Schober KE
    Echocardiographic evaluation of pulmonary vascular resistance in 459 dogs with Doppler-derived pulmonary hypertension.
    J Vet Intern Med. 2026;40:aalag051.
    PubMed         Abstract available
    
    

    
    JACC Asia

45. CAO Y, Dong W, Shi Y, Sun X, et al
    Conceptual Reconsideration of the Classification of Pulmonary Hypertension: From 5 Groups to 2 Groups.
    JACC Asia. 2026 Mar 23:S2772-3747(26)00112-2. doi: 10.1016/j.jacasi.2026.
    PubMed         Abstract available
    
    

    
    JACC Basic Transl Sci

46. KOVACS-KASA A, Annex BH
    Pulmonary Endothelium: A Driver and Therapeutic Target in Pulmonary Hypertension.
    JACC Basic Transl Sci. 2026;11:101528.
    PubMed        
    
    

    
    JACC CardioOncol

47. ALI HR, Faiz SA, Deswal A, Palaskas N, et al
    Sotatercept for the Treatment of Myeloproliferative Neoplasm-Associated Group 5 Pulmonary Hypertension.
    JACC CardioOncol. 2026 Mar 20:S2666-0873(26)00050.
    PubMed        
    
    

    
    JACC Case Rep

48. DRUMMOND R, Forbess L, Lankford A
    Group 5 Pulmonary Hypertension Resulting From Thyrotoxicosis During Pregnancy.
    JACC Case Rep. 2026;31:106656.
    PubMed         Abstract available
    
    

    
    Neonatology

49. ISAAC MAXIMO LM, Assis de Carlos G, Messias Hirano Padrao E, Beshish AG, et al
    Pulmonary Hypertension Association with mortality in Newborns with Giant Omphalocele: A Systematic Review and Meta-Analysis.
    Neonatology. 2026 Mar 30:1-19. doi: 10.1159/000551723.
    PubMed         Abstract available
    
    

    
    Orphanet J Rare Dis

50. PILKA M, Darocha S, Waligora M, Kopec G, et al
    The prevalence and long-term response to calcium channel blockers in patients with pulmonary arterial hypertension and positive vasoreactivity test - results of multicenter national registry (BNP-PL).
    Orphanet J Rare Dis. 2026;21:119.
    PubMed         Abstract available
    
    

    
    Radiol Case Rep

51. CORSI D, Mousa A, Patel D, Albert C, et al
    Multimodality imaging of patent ductus arteriosus with severe pulmonary hypertension following 3 pregnancies.
    Radiol Case Rep. 2026;21:2467-2471.
    PubMed         Abstract available
    
    

    
    Respir Med

52. CHEN Y, Liu M, Liu J, Chen S, et al
    Elevated pulmonary vascular resistance is associated with acute exacerbation admission in patients with chronic obstructive pulmonary disease-related pulmonary hypertension.
    Respir Med. 2026 Mar 30:108801. doi: 10.1016/j.rmed.2026.108801.
    PubMed         Abstract available
    
    

    
    Respir Res

53. GOEL K, Ormesher R, Pratte KA, Wang Y, et al
    Vascular-related proteomic signatures in COPD with suspected pulmonary hypertension as predictors of FEV(1) impairment.
    Respir Res. 2026 Mar 28. doi: 10.1186/s12931-026-03622.
    PubMed        
    
    

    
    Rev Cardiovasc Med

54. ZHAO L, Pang X
    Synergistic Cardiopulmonary Protection of Endothelin Receptor Antagonists Combined With Soluble Guanylate Cyclase Agonists in High-Risk Coronary Syndrome With Pulmonary Hypertension.
    Rev Cardiovasc Med. 2026;27:46401.
    PubMed         Abstract available
    
    

    
    Sarcoidosis Vasc Diffuse Lung Dis

55. OZGUN S, Sari G, Koyuncu A, Ezber R, et al
    Impact of pulmonary hypertension on mortality in progressive massive fibrosis.
    Sarcoidosis Vasc Diffuse Lung Dis. 2026;43:18391.
    PubMed         Abstract available
    
    

    
    Sci Rep

56. ZHANG J, Yan H, Wang Y, Dai Y, et al
    PAK5 drives vascular remodeling in hypoxic pulmonary hypertension via Drp1-dependent mitochondrial midzone division.
    Sci Rep. 2026 Apr 2. doi: 10.1038/s41598-026-46809.
    PubMed        
    
    

    
    Turk Kardiyol Dern Ars

57. KULA S
    Pulmo: Patient Education in Pulmonary Hypertension via Artificial Intelligence-Based Digital Characters.
    Turk Kardiyol Dern Ars. 2026 Mar 27. doi: 10.5543/tkda.2026.07902.
    PubMed        
    
    

    
    Zhongguo Dang Dai Er Ke Za Zhi

58. YAO ZZ, Yu AZ, Feng X
    [A Meta analysis of risk factors for pulmonary hypertension related to bronchopulmonary dysplasia in preterm infants].
    Zhongguo Dang Dai Er Ke Za Zhi. 2026;28:293-300.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Pulmonary Hypertension is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum